Altered expression of the TCR signaling related genes CD3 and FcRI in patients with aplastic anemia

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Li, Bo ^a,b   Liu, Sichu ^a   Niu, Yuzhe ^a   Fang, Su ^a   Wu, Xiuli ^a   Yu, Zhi ^a   Chen, Shaohua ^a   Yang, Lijian ^a   Li, Yangqiu ^a,b  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Aplastic anemia; CD3; FcRI; Gene expression

Indexed keywords

BETA 2 MICROGLOBULIN; CD3 ANTIGEN; CD3 DELTA ANTIGEN; CD3 EPSILON ANTIGEN; CD3 GAMMA ANTIGEN; CD3 ZETA ANTIGEN; FC EPSILON RECEPTOR TYPE I GAMMA; FC RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; FCEPSILONRI GAMMA CHAIN, HUMAN; FCEPSILONRI GAMMA-CHAIN, HUMAN; IMMUNOGLOBULIN E RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SIGNAL TRANSDUCTION; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANTIGENS, CD3; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IGE; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84862795041     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-6     Document Type: Article

References (33)

1. Aplastic anemia. Young NS, Scheinberg P, Calado RT, Curr Opin Hematol 2008 15 162 168 10.1097/MOH.0b013e3282fa7470 18391779 (Pubitemid 351507566)
2. Clinical observations on intensive immunosuppressive therapy combined with umbilical cord blood support for the treatment of severe aplastic anemia. Zhou F, Ge L, Yu Z, Fang Y, Kong F, J Hematol Oncol 2011 4 27 10.1186/1756-8722-4-27 21663651
3. HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia. Sun ZM, Liu HL, Geng LQ, Wang XB, Yao W, Liu X, Ding KY, Han YS, Yang HZ, Tang BL, Tong J, Zhu WB, Wang ZY, J Hematol Oncol 2010 3 51 10.1186/1756-8722-3-51 21194460
4. Circulating activated suppressor T lymphocytes in aplastic anemia. Zoumbos NC, Gasco'n P, Djeu JY, Trost SR, Young NS, N Engl J Med 1985 312 257 265 10.1056/NEJM198501313120501 2981406 (Pubitemid 15199363)
5. + cells of patients with aplastic anaemia. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS, Br J Haematol 1995 91 245 252 10.1111/j.1365-2141.1995.tb05277.x 7577642
6. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Zoumbos NC, Gascon P, Djeu JY, Young NS, Proc Natl Acad Sci USA 1985 82 188 192 10.1073/pnas.82.1.188 3918301 (Pubitemid 15168240)
7. Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, Young NS, Blood 2002 100 1185 1191 10.1182/blood-2002-01-0035 12149196 (Pubitemid 34864270)
8. Etanercept as a salvage treatment for refractory aplastic anemia. Dufour C, Giacchino R, Ghezzi P, Tonelli R, Ferretti E, Pitto A, Pistoia V, Lanza T, Svahn J, Pediatr Blood Cancer 2009 52 522 525 10.1002/pbc.21886 19061218
9. Current concepts in the pathophysiology and treatment of aplastic anemia. Young NS, Calado RT, Scheinberg P, Blood 2006 108 2509 2519 10.1182/blood-2006-03-010777 16778145
10. Stoichiometry of T-cell receptor-CD3 complex and key intermediates assembled in the endoplasmic reticulum. Call ME, Pyrdol J, Wucherpfenning KW, EMBO J 2004 23 2348 2357 10.1038/sj.emboj.7600245 15152191 (Pubitemid 38954842)
11. T cell receptor complexes containing Fc epsilon RI gamma homodimers in lieu of CD3 zeta and CD3 eta components: a novel isoform expressed on large granular lymphocytes. Koyasu S, D'Adamio L, Arulanandam AR, Abraham S, Clayton LK, Reinherz EL, J Exp Med 1992 175 203 209 10.1084/jem.175.1.203 1530959
12. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Enyedy EJ, Nambiar MP, Liossis SN, Dennis G, Kammer GM, Tsokos GC, Arthritis Rheum 2001 44 1114 1121 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3. 0.CO;2-B 11352243 (Pubitemid 32433617)
13. Th1/Th2 lymphocyte balance in patients with aplastic anemia. Kaito K, Otsubo H, Usui N, Kobayashi M, Rinsho Byori 2004 52 569 573 15344555
14. T cell receptor repertoire of T cells in the kidneys of patients with lupus nephritis. Murata H, Matsumura R, Koyama A, et al. Arthritis Rheum 2002 46 2141 2147 10.1002/art.10432 12209519
15. Analysis of accumulated T cell clonotypes in patients with systemic lupus erythematosus. Kato T, Kurokawa M, Sasakawa H, Masuko-Hongo K, Matsui T, Sekine T, Tanaka C, Yamamoto K, Nishioka K, Arthritis Rheum 2000 43 2712 2721 10.1002/1529-0131(200012)43:12<2712::AID-ANR11>3.0.CO;2-T 11145029 (Pubitemid 32001737)
16. Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: evidence for antigenic selection of T cells in the synovium. Thompson SD, Murray KJ, Grom AA, Passo MH, Choi E, Glass DN, Arthritis Rheum 1998 41 482 497 10.1002/1529-0131(199803)41:3<482::AID-ART15>3.0.CO;2-G 9506577 (Pubitemid 28128774)
17. Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies. Amemiya K, Granger RP, Dalakas MC, Brain 2000 123 2030 2039 10.1093/brain/123.10.2030 11004120
18. Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases. Ciszak L, Pawlak E, Kosmaczewska A, Potoczek S, Frydecka I, Arch Immunol Ther Exp (Warsz) 2007 55 373 386 10.1007/s00005-007-0042-6
19. Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseases. Li Y, Hematology 2008 13 267 275 10.1179/102453308X343482 18854088
20. Deficiency of CD3gamma, delta, epsilon and zeta expression in T-cells from AML patients. Chen S, Zha X, Yang L, Li B, Zhong L, Li Y, Hematology 2011 16 31 36 10.1179/102453311X12902908411832 21269565
21. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
22. The T-cell receptor/CD3 complex: A dynamic protein ensemble. Clevers H, Alarcon B, Wileman T, Terhorst C, Annu Rev Immunol 1988 6 629 662 10.1146/annurev.iy.06.040188.003213 3289580 (Pubitemid 19141599)
23. Molecular mechanisms for the assembly of the T cell receptor-CD3 complex. Call ME, Wucherpfenning KW, Mol Immunol 2004 40 1295 1305 10.1016/j.molimm. 2003.11.017 15072848 (Pubitemid 38456981)
24. The T-cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Wegener AM, Letourneur F, Hoeveler A, Brocker T, Luton F, Malissen B, Cell 1992 68 83 95 10.1016/0092-8674(92)90208-T 1531041
25. An evolutionary and structural perspective on T-cell antigen receptor function. Malissen B, Immunol Rev 2003 191 7 27 10.1034/j.1600-065X.2003.00016.x 12614348 (Pubitemid 36398845)
26. The CD3 gamma epsilon/delta epsilon signaling module provides normal T cell functions in the absence of the TCR zeta immunoreceptor tyrosine-based activation motifs. Pitcher LA, Mathis MA, Young JA, DeFord LM, Purtic B, Wulfing C, van Oers NS, Eur J Immunol 2005 35 3643 3654 10.1002/eji.200535136 16259006 (Pubitemid 43025544)
27. Decreased TCR zeta-chain expression in T cells from patients with acquired aplastic anaemia. Solomou EE, Wong S, Visconte V, Gibellini F, Young NS, Br J Haematol 2007 138 72 76 10.1111/j.1365-2141.2007.06627.x 17555449 (Pubitemid 46889791)
28. Tolerance of T-cell clones is associated with membrane antigen changes. Zanders ED, Lamb JR, Feldmann M, Green N, Beverley PC, Nature 1983 303 625 627 10.1038/303625a0 6343888 (Pubitemid 13099977)
29. Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE. Shiue L, Zoller MJ, Brugge JS, J Biol Chem 1995 270 10498 10502 10.1074/jbc.270.18.10498 7537732
30. Inhibition of mast cell FcRI-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. Oliver JM, Burg D, Wilson BS, McLaughlin JL, Geahlen RL, J Biol Chem 1994 269 29697 29703 7961959
31. Differential activation of the tyrosine kinases ZAP-70 and Syk after FcgRI stimulation. Taylor N, Jahn T, Smith S, Lamkin T, Uribe L, Liu Y, et al. Blood 1997 89 388 396 9002939 (Pubitemid 27051672)
32. The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells. Krishnan S, Warke VG, Nambiar MP, Tsokos GC, Farber DL, J Immunol 2003 170 4189 4195 12682251 (Pubitemid 36428184)
33. TCR signal transduction in antigen-specific memory CD8 T cells. Kersh EN, Kaech SM, Onami TM, Moran M, Wherry EJ, Miceli MC, Ahmed R, J Immunol 2003 170 5455 5454 12759421